The settlement involves three drugs, including Risperdal, used to treat schizophrenia.... On Monday, Johnson & Johnson defended Risperdal "as safe and effective for its approved indications...
Global health care giant Johnson & Johnson (J&J) and its subsidiaries will pay more than $2.2 billion to resolve criminal and civil liability arising from allegations relating to the prescription d...
Johnson & Johnson said it has settled most of the lawsuits it faced by thousands of men who claimed its anti-psychotic drug Risperdal caused them to develop excessive breast tissue and disclosed th...
Johnson & Johnson and a subsidiary were ordered to pay $8 billion in punitive damages after lawyers argued anitpsychotic drug Risperdal was linked to abnormal growth of female breast tissue in boys.
Johnson & Johnson Headquarters at One Johnson and Johnson... 6 Illegal marketing of Risperdal 6.7 Foreign bribery 6.8... 1 Northeastern Ohio Settlement 7 Public-private engagement 7.1...
Johnson & Johnson has agreed to pay more than $2.2 billion to resolve criminal and civil allegations that the company promoted powerful psychiatric drugs for unapproved uses in children, seniors an...
Johnson & Johnson will pay $2.2 billion to settle civil and criminal investigations related to mis-marketing of prescription drugs Risperdal, Invega and Natrecor.
after Johnson & Johnson agreed on Monday to pay $2.2 billion to... The settlement with the federal government and 45 states ends a decade-long inquiry into Risperdal Consta, one of the...
States, the federal government and thousands of individuals have filed lawsuits over the drug Risperdal, costing the drugmaker Johnson & Johnson billions.
Federal prosecutors also say, as part of the civil settlement, that Johnson & Johnson promoted the use of Risperdal in people with mental disabilities and children, even though the company...